The store will not work correctly when cookies are disabled.
2-(4-nitrophenyl)sulfonylisoindoline-1,3-dione
ID: ALA4876110
PubChem CID: 85828254
Max Phase: Preclinical
Molecular Formula: C14H8N2O6S
Molecular Weight: 332.29
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2ccccc2C(=O)N1S(=O)(=O)c1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C14H8N2O6S/c17-13-11-3-1-2-4-12(11)14(18)15(13)23(21,22)10-7-5-9(6-8-10)16(19)20/h1-8H
Standard InChI Key: XKBXPAOROVRSIW-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
14.0450 -1.3125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2596 -2.1049 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.8385 -1.5228 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2277 -3.1367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4821 -2.3600 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8191 -1.8779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8179 -1.0607 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7073 -3.7984 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8662 -2.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6897 -3.4553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2955 -4.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0772 -3.7569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2497 -2.9512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6426 -2.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6835 -4.3067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4616 -4.0567 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5110 -5.1054 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4119 -3.1364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1595 -2.3571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3600 -2.1874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8122 -2.7961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0693 -3.5771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8682 -3.7431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
18 4 1 0
4 5 1 0
5 6 1 0
6 19 1 0
6 7 2 0
4 8 2 0
5 2 1 0
2 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
15 16 2 0
15 17 1 0
12 15 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M CHG 2 15 1 17 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.29 | Molecular Weight (Monoisotopic): 332.0103 | AlogP: 1.58 | #Rotatable Bonds: 3 |
Polar Surface Area: 114.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.23 | CX LogD: 2.23 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.48 | Np Likeness Score: -1.20 |
References
1. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |